Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company focused on developing disease-modifying therapies for rare, pediatric lysosomal storage disorders (LSDs), today announced ...
Hosted on MSN
US Iran war highlights: Trump's 'ticking clock' warning to Tehran, says 'must' for it to stop funding Hezbollah
Live updates to this blog ends here. Follow here for updates US Iran LIVE updates: US President Donald Trump on Thursday said ...
On 9 March 2026, Ipsen announced the voluntary withdrawal of Tazverik ® (tazemetostat) from all indications and all Ipsen markets, effective immediately, following emerging safety data from the ...
EBITDA OF EUR 6.2 MILLION ON THE NEW SCOPE - POSITIVE FREE CASH FLOW - MAJOR NEW CONTRACT CURRENTLY BEING FINALIZED ...
Establishment Labs Holdings Inc. , a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its ...
APRIL 2026 at 12:00 EEST Orion Group Interim report January-March 2026 January-March 2026 Highlights Net sales totalled EUR 417.7 (January-March 2025: 354.6) ...
Shore Bancshares, Inc. (the "Company" or "Shore Bancshares"), the holding company for Shore United Bank, N.A. (the "Bank"), reported record net income for the first quarter of 2026 of $17.1 million, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results